Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 16 | 0 | 4 | 0 | €98.76 | €116.81 | 18.274% |
| AbbVie Inc. | 20 | 1 | 3 | 1 | €149.92 | €174.43 | 16.351% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €3.80 | €34.41 | 805.595% |
| AC Immune Ltd | 4 | 0 | 0 | 0 | €2.41 | €12.27 | 410.337% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.15 | €8.50 | 4.294% |
| Addus Homecare Corp. | 11 | 1 | 0 | 1 | €86.50 | €98.14 | 13.460% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Affimed N.V. | 8 | 6 | 0 | 0 | €0.55 | €6.54 | 1083.165% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €129.76 | €133.66 | 3.006% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.22 | €3.60 | 195.735% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.52 | €38.19 | 95.714% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.96 | - | - |
| Align Technology | 15 | 2 | 4 | 0 | €267.20 | €345.95 | 29.472% |
| Alkermes plc | 12 | 2 | 1 | 0 | €22.80 | €34.08 | 49.477% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €140.00 | €228.30 | 63.071% |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €84.50 | €92.26 | 9.183% |
| Amgen Inc. | 21 | 0 | 3 | 0 | €259.65 | €294.28 | 13.338% |
| AnaptysBio Inc | 7 | 1 | 2 | 0 | €22.80 | €46.24 | 102.807% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.20 | €26.58 | 9.840% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €42.56 | €70.00 | 64.493% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.32 | €11.00 | 74.161% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €134.00 | €150.00 | 11.940% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €141.30 | €165.00 | 16.773% |
| Atossa Genetics Inc | 5 | 1 | 2 | 0 | €1.45 | €3.72 | 156.796% |